This inventor holds 8 USPTO granted patents and 9 published patent applications and 5 EPO patents. Top assignees: Urogen Pharma Ltd., Theracoat Ltd.. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Herzliya, IL (2017)
- Hertzyla, IL (2015 - 2018)
- Hertzlya, IL (2018)
- Netanya, IL (2019)
- Herzilya, IL (2020)
Company Filing History:
Years Active: 2015-2025
Title: The Innovative Contributions of Inventor Marina Konorty
Introduction
Marina Konorty, an accomplished inventor based in Hertzyla, IL, has made significant strides in the field of cancer treatment through her innovative approaches. With a total of seven patents to her name, she has contributed to advancements in pharmaceutical compositions and methods aimed at improving patient outcomes.
Latest Patents
Among her latest patents, Konorty has developed a pioneering material and method for treating cancer. This involves the formation of pharmaceutical compositions designed for a sustained release of therapeutic agents targeted at local treatment of cancer diseases. Specifically, her work focuses on embedding lyophilized mitomycin C within a slowly releasing biocompatible hydrogel, applied directly to the affected tissue. The innovative aspect of her patent lies in the specific composition of mitomycin C, which is lyophilized with urea as a bulking agent in a precise ratio ranging from 1:7 to 1:9.
Additionally, she has patented methods for immunomodulating treatments of body cavities. This involves compositions and methods to treat cancers of body cavities, notably urinary tract cancer, utilizing a combination of at least two immunomodulatory agents. Some of these therapeutic agents are embedded in a biocompatible hydrogel for slow release, enhancing treatment efficacy.
Career Highlights
Konorty has worked with notable companies in the pharmaceutical domain, including Urogen Pharma Ltd. and Theracoat Ltd. Her work in these organizations has allowed her to develop and refine her patented techniques, which are crucial in the fight against cancer.
Collaborations
Throughout her career, Marina Konorty has collaborated with several professionals in the field, including Asher Holzer and Dorit Daniel. These partnerships have facilitated the sharing of ideas and expertise, further enhancing the quality and impact of her innovations.
Conclusion
Marina Konorty's contributions to the field of cancer treatment are noteworthy and reflect her dedication to innovation. With her extensive research and patent portfolio, she continues to pave the way for new therapies that can improve the lives of patients suffering from cancer. Her work not only showcases her skills as an inventor but also emphasizes the importance of collaboration and innovation in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile